Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 4
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.
Listì A, Barraco N, Bono M, Insalaco L, Castellana L, Cutaia S, Ricciardi MR, Gristina V, Bronte E, Pantuso G, Passiglia F. Listì A, et al. Among authors: castellana l. Transl Cancer Res. 2019 Jan;8(Suppl 1):S55-S63. doi: 10.21037/tcr.2018.10.04. Transl Cancer Res. 2019. PMID: 35117064 Free PMC article. Review.
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis.
Galvano A, Incorvaia L, Badalamenti G, Rizzo S, Guarini A, Cusenza S, Castellana L, Barraco N, Calò V, Cutaia S, Currò G, Silvestris N, Beretta GD, Bazan V, Russo A. Galvano A, et al. Among authors: castellana l. Cancers (Basel). 2019 Aug 15;11(8):1189. doi: 10.3390/cancers11081189. Cancers (Basel). 2019. PMID: 31443300 Free PMC article. Review.
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials.
Galvano A, Scaturro D, Badalamenti G, Incorvaia L, Rizzo S, Castellana L, Cusenza S, Cutaia S, Santini D, Guadagni F, Roselli M, Gori S, Latteri MA, Bazan V, Giulia LM, Russo A. Galvano A, et al. Among authors: castellana l. J Bone Oncol. 2019 Jul 16;18:100252. doi: 10.1016/j.jbo.2019.100252. eCollection 2019 Oct. J Bone Oncol. 2019. PMID: 31440444 Free PMC article. Review.
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis.
Galvano A, Castellana L, Gristina V, La Mantia M, Insalaco L, Barraco N, Perez A, Cutaia S, Calò V, Bazan Russo TD, Francini E, Incorvaia L, Mirisola MG, Vieni S, Rolfo C, Bazan V, Russo A. Galvano A, et al. Among authors: castellana l. Ther Adv Med Oncol. 2022 Sep 26;14:17588359221110162. doi: 10.1177/17588359221110162. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36188485 Free PMC article.
Opioids in advanced cancer: use, storage and disposal in the home.
Mercadante S, Adamoli L, Bellavia G, Castellana L, Favara T, Insalaco L, Mauceri M, Scibilia C, Lo Mauro M, Lo Cascio A, Casuccio A. Mercadante S, et al. Among authors: castellana l. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e855-e858. doi: 10.1136/spcare-2022-003964. BMJ Support Palliat Care. 2024. PMID: 36175123
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study.
Gristina V, Barraco N, La Mantia M, Castellana L, Insalaco L, Bono M, Perez A, Sardo D, Inguglia S, Iacono F, Cutaia S, Bazan Russo TD, Francini E, Incorvaia L, Badalamenti G, Russo A, Galvano A, Bazan V. Gristina V, et al. Among authors: castellana l. Cancers (Basel). 2022 Dec 6;14(23):6013. doi: 10.3390/cancers14236013. Cancers (Basel). 2022. PMID: 36497493 Free PMC article.
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses.
Gristina V, Galvano A, Castellana L, Insalaco L, Cusenza S, Graceffa G, Iacono F, Barraco N, Castiglia M, Perez A, Rizzo S, Russo A, Bazan V. Gristina V, et al. Among authors: castellana l. Ther Adv Med Oncol. 2021 Jul 21;13:17588359211018018. doi: 10.1177/17588359211018018. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34646363 Free PMC article.
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials.
Santini D, Galvano A, Pantano F, Incorvaia L, Rizzo S, Vincenzi B, Castellana L, Giuliana G, Guadagni F, Toia F, Tonini G, Russo A, Badalamenti G, Bazan V. Santini D, et al. Among authors: castellana l. Crit Rev Oncol Hematol. 2019 Oct;142:68-75. doi: 10.1016/j.critrevonc.2019.07.013. Epub 2019 Jul 25. Crit Rev Oncol Hematol. 2019. PMID: 31377434